SAI LIFE SCIENCES LIMITED (SAILIFE) Share Price Hits 52-Week High
- July 31, 2026
- Posted by: Harsh Piplani
- Category: News
SAI LIFE SCIENCES LIMITED Share Price hits a fresh 52-week high at Rs 1,325, marking a 0.44% increase today with a market cap of Rs 27,889.18 Cr.
SAI LIFE SCIENCES LIMITED Share Price has reached a fresh 52-week high of Rs 1,325, reflecting a 0.44% increase from the previous close of Rs 1,314.45. The current market capitalisation stands at Rs 27,889.18 crore, highlighting the company’s significant presence in the healthcare sector. This milestone in the share price underscores investor interest, although the data does not specify a company-specific catalyst for this rise.
SAI LIFE SCIENCES LIMITED Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,320.2 |
| Previous Close | Rs 1,314.45 |
| Today's Change | +Rs 5.75 (+0.44%) |
| Day Open | Rs 1,321.25 |
| Fresh 52-Week High | Rs 1,325 |
| Day Low | Rs 1,302.7 |
| Current Volume | 6,475 |
| Turnover | Rs 0.85 crore |
| Market Capitalisation | Rs 27,889.18 crore |
SAI LIFE SCIENCES LIMITED (SAILIFE) traded at Rs 1,320.2. versus the previous close of Rs 1,314.45, a rise of 0.44%. The stock opened at Rs 1,321.25, reached Rs 1,325, touched Rs 1,302.7. Reported volume was 6,475.
Today, SAI LIFE SCIENCES LIMITED opened at Rs 1,321.25 and reached a high of Rs 1,325, setting a new 52-week high. The stock’s low for the day was Rs 1,302.7, with a turnover of Rs 0.85 crore. The current volume of 6,475 shares indicates moderate trading activity. The 0.44% increase from the previous close suggests a positive sentiment among investors, aligning with the stock’s upward momentum.
SAI LIFE SCIENCES LIMITED (SAILIFE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 27,889.18 crore |
| P/E Ratio | 39.17x |
| P/B Ratio | 7.93x |
| ROE | 28.21% |
| ROCE | 26.35% |
SAI LIFE SCIENCES LIMITED was valued at a P/E ratio of 39.17x, a P/B ratio of 7.93x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of 28.21% and ROCE of 26.35%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 39.17x |
| Benchmark Median P/E | 20.13x |
| Benchmark Average P/E | 73.73x |
| Benchmark P/E Range | 0x to 3,417.8x |
| Company P/B Ratio | 7.93x |
| Benchmark Median P/B | 1.92x |
| Company ROE | 28.21% |
| Benchmark Median ROE | 10.73% |
| Company ROCE | 26.35% |
| Benchmark Median ROCE | 13.2% |
| Company Market Capitalisation | Rs 27,889.18 crore |
| Benchmark Median Market Cap | Rs 140.91 crore |
SAI LIFE SCIENCES LIMITED (SAILIFE) is classified under sector: Healthcare.
SAI LIFE SCIENCES LIMITED (SAILIFE) has a P/E ratio of 39.17x, which is above the benchmark median of 20.13x, a difference of +94.59%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
SAI LIFE SCIENCES LIMITED (SAILIFE) has a ROE of 28.21%, which is above the benchmark median of 10.73%, a difference of +162.91%. SAI LIFE SCIENCES LIMITED (SAILIFE) has a ROCE of 26.35%, which is above the benchmark median of 13.2%, a difference of +99.62%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Kwality Pharmaceuticals Ltd. | KPL | 2,700.98 | 39.17 | 7.93 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,475.7 | 58.88 | 9.32 | 18.65 | 22.17 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,439.14 | 165.82 | 3.06 | 13.9 | 12.97 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,424.44 | 34.59 | 7 | -2.6 | 16.92 |
| Venus Remedies Ltd. | VENUSREM-BE | 2,150.28 | 17.79 | 3.01 | 9.85 | 7.89 |
SAI LIFE SCIENCES LIMITED (SAILIFE) has a P/E ratio of 39.17x compared with the displayed peer median of 39.17x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 28.21% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 26.35% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. SAI LIFE SCIENCES LIMITED (SAILIFE) has a market capitalisation of Rs 27,889.18 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching SAI LIFE SCIENCES LIMITED
- SAI LIFE SCIENCES LIMITED Share Price reached a fresh 52-week high, indicating strong market interest.
- The company’s fundamentals, including high ROE and ROCE, suggest robust financial health.
- Its valuation metrics are above sector medians, reflecting investor confidence.
- SAI LIFE SCIENCES LIMITED’s market cap positions it as a leader in the healthcare sector.
About SAI LIFE SCIENCES LIMITED
SAI LIFE SCIENCES LIMITED is a prominent player in the healthcare sector, known for its innovative solutions and comprehensive services. The company operates across various segments, providing a wide range of products and services that cater to the pharmaceutical and healthcare industries. Its strong market position is supported by a robust portfolio and a commitment to quality and innovation.
Track SAI LIFE SCIENCES LIMITED Share Price on Univest
Use SAI LIFE SCIENCES LIMITED (SAILIFE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors can track the live share price of SAI LIFE SCIENCES LIMITED, along with technical indicators, fundamental ratios, shareholding patterns, 52-week levels, and market insights on Univest.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current share price of SAI LIFE SCIENCES LIMITED?
Ans. The current share price of SAI LIFE SCIENCES LIMITED is Rs 1,320.2, reflecting a 0.44% increase from the previous close. The stock moved 0.44% during the session. The intraday range extended from Rs 1,302.7 to Rs 1,325.
What is the 52-week high of SAI LIFE SCIENCES LIMITED?
Ans. The 52-week high of SAI LIFE SCIENCES LIMITED is Rs 1,325, achieved today, indicating strong market performance. The stock moved 0.44% during the session. The intraday range extended from Rs 1,302.7 to Rs 1,325.
How does SAI LIFE SCIENCES LIMITED's P/E ratio compare to the sector?
Ans. SAI LIFE SCIENCES LIMITED's P/E ratio of 39.17 is higher than the sector median of 20.13, suggesting a premium valuation. The company trades at a P/E ratio of 39.17x. Its P/B ratio is 7.93x.
What is SAI LIFE SCIENCES LIMITED's market capitalisation?
Ans. SAI LIFE SCIENCES LIMITED's market capitalisation is Rs 27,889.18 crore, highlighting its significant presence in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 39.17x.
How does SAI LIFE SCIENCES LIMITED's ROE compare to its peers?
Ans. SAI LIFE SCIENCES LIMITED's ROE of 28.21% is superior to many of its peers, indicating strong profitability. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.73%.
What is the P/B ratio of SAI LIFE SCIENCES LIMITED?
Ans. The P/B ratio of SAI LIFE SCIENCES LIMITED is 7.93, which is above the sector median of 1.92, reflecting a higher valuation. The company trades at a P/E ratio of 39.17x.
Who are some of SAI LIFE SCIENCES LIMITED's peers?
Ans. Peers of SAI LIFE SCIENCES LIMITED include Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., and Sai Parenteral's Ltd., among others. Comparable listed companies include Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., Sai Parenteral's Ltd.
How does SAI LIFE SCIENCES LIMITED's ROCE compare to the sector?
Ans. SAI LIFE SCIENCES LIMITED's ROCE of 26.35% is significantly above the sector median of 13.2%, showcasing efficient capital use. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.73%.
